Oak Investment Partners
Wilton · Seed–Late Stage · 10 people tracked
Investment thesis
Oak pursues significant opportunities with market-dislocating potential through innovation and long-term relationships. The firm supports companies from formation through growth stages, including fund spinouts and PIPE investments in public companies. Oak emphasizes senior team expertise, consistent investment philosophy, and an ability to identify and capitalize on emerging trends across its core sectors.
Source: firm website, verified Jul 17, 2026.
Team · 10 people
from the firm's websiteFrequently asked questions
- What stage does Oak Investment Partners invest at?
- Oak Investment Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Oak Investment Partners focus on?
- Oak Investment Partners focuses on AI & Machine Learning, Cleantech, Climate Tech, Consumer, Digital Health, Enterprise Software, Fintech, Healthtech.
- Where is Oak Investment Partners located?
- Oak Investment Partners is headquartered in Wilton, US.
- Does Oak Investment Partners lead rounds?
- Yes, Oak Investment Partners leads investment rounds.
Similar investors
A deep technology venture capital firm investing in companies solving major global challenges across climate change, human health, defense, security, space, and physically intensive industries.
Octopus Ventures is a major venture capital investor in Europe focused on backing entrepreneurs addressing global challenges across sustainability, human empowerment, and healthcare innovation.
An early-stage venture capital firm focused on identifying and investing in founders across diverse technology and innovation sectors.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz with over $100B under management. The firm invests across seed to growth-stage technology companies and operates with one of the largest platforms of operators in venture, providing support in marketing, talent, legal, and policy.
Osage University Partners invests in breakthrough startups emerging from leading research labs and innovation ecosystems, with a focus on tech and life science companies. The firm manages $800 million and has 150+ portfolio companies across all investment stages from pre-seed to crossover.